Listed

Chemkart India Ltd. IPO

Chemkart India Limited, engaged in supplying nutraceutical and pharmaceutical ingredients, is launching its IPO on July 7 with a price band of ₹236–248. The company plans to raise ₹80 crore through this issue, which will help in setting up a new facility, repaying existing loans, and meeting working capital needs in the growing health supplement industry.

RHP DRHP Anchor Investor link Check Allotment Status

Min Investment

₹1,48,800

Lot Size

600 Shares

Price Range

₹236-248

Issue Size (₹ Cr.)

₹80.08

IPO Type

BSE SME

Key Metrics

Face Value

₹ 10

GMP

₹ 0.00

Subscription

0.59x

EPS

₹ 20.05

P/E Ratio

12.37 x

RoNW

45.52%

ROE

59%

Debt to Equity (₹ Cr.)

0.32

Timeline

IPO Opened07/07/2025Monday

IPO Closed09/07/2025Wednesday

Allotted10/07/2025Thursday

Refunded11/07/2025Friday

Listed14/07/2025Monday

Strengths

Wide Product Range - Chemkart offers a diverse portfolio of nutraceutical ingredients including vitamins, proteins, herbal extracts, and amino acids, catering to the health and wellness industry.
In-House Operations - The company has its own warehousing, blending, and packaging facility, ensuring better control over product quality and logistics.
Strategic Location - Its proximity to Mumbai port supports efficient import and export operations, giving it a logistical advantage.
Growing Market Demand - With rising awareness of health and nutrition, demand for nutraceutical products is increasing, supporting business growth.
Expansion-Focused IPO - Funds from the IPO will be used for setting up a manufacturing unit and enhancing operational capacity, which may boost scalability.

Weaknesses

Supplier Dependency - The company relies on a limited number of international suppliers for raw materials, increasing supply chain risk.
Import Reliance - Heavy dependence on imports, especially from China, exposes the business to currency and geopolitical risks.
Limited Operating History - Being incorporated in 2020, the company lacks a long operational track record, which may concern conservative investors.
Cash Flow Volatility - Chemkart has shown fluctuations in its operating cash flow, indicating working capital challenges.
Geographic Concentration - Most of its revenues come from select regions in India, making the business vulnerable to regional market changes.